Clinical Trials
3 trialsNCT04284488 2026-01-08
Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors
Ascentage Pharma Group Inc.
Phase 1/2 Terminated
NCT04643405 2026-01-08
APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma
Ascentage Pharma Group Inc.
Phase 1/2 Terminated
NCT03386526 2023-02-01
APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies
Ascentage Pharma Group Inc.
Phase 1 Completed